Name:
Autoimmune Pulmonary Alveolar Proteinosis
Description:
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA-2)
Stage:
Recruiting
Principal Investigator:
Prof Cormac McCarthy
Sponsor:
Savara
Network Partners
